Tanya Gurevich

7PUBLICATIONS
36CO-AUTHORS
Molecular targetsGenomicsPacific Peoples and disabilityPharmacogenomicsPeripheral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 25, 2026
LRRK2-targeting antisense oligonucleotide in Parkinson's disease: a phase 1 randomized controlled trial.

Omar S Mabrouk, Ben Tichler, H Moore Arnold

|Jan 23, 2026
Analysis of α-synuclein seed amplification assay in carriers of GBA1 and LRRK2 pathogenic variants.

Kyle B Fraser, Anat Mirelman, Omar S Mabrouk

|Aug 15, 2025
Levodopa-Carbidopa Intestinal Gel Improves Dyskinesia in Parkinson's Disease: Post Hoc Analysis from the COSMOS Study.

Alfonso Fasano, Cleanthe Spanaki, Tanya Gurevich

|Nov 27, 2024
The Interplay of Stress, Inflammation, and Metabolic Factors in the Course of Parkinson's Disease.

Tal Ben Shaul, Dan Frenkel, Tanya Gurevich

|Nov 15, 2024
Discriminating Parkinson's disease patients from healthy controls using nasal respiratory airflow.

Michal Andelman-Gur, Kobi Snitz, Danielle Honigstein

|Mar 25, 2022
Switching and Combining Device-Aided Therapies in Advanced Parkinson's Disease: A Double Centre Retrospective Study.

Dejan Georgiev, Sentilija Delalić, Nina Zupančič Križnar

Pageof 2